TNGX logo

Tango Therapeutics, Inc. (TNGX) Shareholders Equity

Annual Shareholders Equity:

$199.52M-$53.59M(-21.17%)
December 31, 2024

Summary

  • As of today, TNGX annual stockholders equity is $199.52 million, with the most recent change of -$53.59 million (-21.17%) on December 31, 2024.
  • During the last 3 years, TNGX annual shareholders equity has fallen by -$145.23 million (-42.13%).
  • TNGX annual shareholders equity is now -42.13% below its all-time high of $344.75 million, reached on December 31, 2021.

Performance

TNGX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXbalance sheet metrics

Quarterly Shareholders Equity:

$160.03M+$25.08M(+18.58%)
September 30, 2025

Summary

  • As of today, TNGX quarterly stockholders equity is $160.03 million, with the most recent change of +$25.08 million (+18.58%) on September 30, 2025.
  • Over the past year, TNGX quarterly shareholders equity has dropped by -$69.14 million (-30.17%).
  • TNGX quarterly shareholders equity is now -56.21% below its all-time high of $365.41 million, reached on September 30, 2021.

Performance

TNGX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

TNGX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-21.2%-30.2%
3Y3 Years-42.1%-41.4%
5Y5 Years+416.9%-1.5%

TNGX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-42.1%at low-42.1%+18.6%
5Y5-Year-42.1%+416.9%-56.2%+314.6%
All-TimeAll-Time-42.1%+416.9%-56.2%>+9999.0%

TNGX Shareholders Equity History

DateAnnualQuarterly
Sep 2025
-
$160.03M(+18.6%)
Jun 2025
-
$134.95M(-19.1%)
Mar 2025
-
$166.76M(-16.4%)
Dec 2024
$199.52M(-21.2%)
$199.52M(-12.9%)
Sep 2024
-
$229.17M(-7.5%)
Jun 2024
-
$247.67M(-6.3%)
Mar 2024
-
$264.45M(+4.5%)
Dec 2023
$253.11M(+1.5%)
$253.11M(-8.5%)
Sep 2023
-
$276.60M(+29.9%)
Jun 2023
-
$212.94M(-6.3%)
Mar 2023
-
$227.26M(-8.9%)
DateAnnualQuarterly
Dec 2022
$249.48M(-27.6%)
$249.48M(-8.6%)
Sep 2022
-
$273.07M(-8.6%)
Jun 2022
-
$298.70M(-6.8%)
Mar 2022
-
$320.36M(-7.1%)
Dec 2021
$344.75M(+793.1%)
$344.75M(-5.7%)
Sep 2021
-
$365.41M(+126.5%)
Jun 2021
-
$161.36M(-0.5%)
Mar 2021
-
$162.12M(+320.0%)
Dec 2020
$38.60M
$38.60M(-76.2%)
Sep 2020
-
$162.43M(>+9900.0%)
Jun 2020
-
$24.50K

FAQ

  • What is Tango Therapeutics, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. annual shareholders equity year-on-year change?
  • What is Tango Therapeutics, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. quarterly shareholders equity year-on-year change?

What is Tango Therapeutics, Inc. annual stockholders equity?

The current annual shareholders equity of TNGX is $199.52M

What is the all-time high annual shareholders equity for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high annual stockholders equity is $344.75M

What is Tango Therapeutics, Inc. annual shareholders equity year-on-year change?

Over the past year, TNGX annual stockholders equity has changed by -$53.59M (-21.17%)

What is Tango Therapeutics, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of TNGX is $160.03M

What is the all-time high quarterly shareholders equity for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high quarterly stockholders equity is $365.41M

What is Tango Therapeutics, Inc. quarterly shareholders equity year-on-year change?

Over the past year, TNGX quarterly stockholders equity has changed by -$69.14M (-30.17%)
On this page